LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) › Cash & EquivalentsLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $43.46M2010: $27.82M2011: $8.13M2012: $22.18M2013: $13.72M2014: $14.24M2015: $14.13M2016: $9.97M2017: $6.00M2018: $2.90M2019: $1.08M2020: $2.48M2021: $609.0K2022: $5.94M2023: $19.09M2024: $8.46M2025: $17.47M$17.47M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$17.47M+106.4%2024$8.46M-55.7%2023$19.09M+221.5%2022$5.94M+875.0%2021$609.0K-75.4%2020$2.48M+129.3%2019$1.08M-62.7%2018$2.90M-51.7%2017$6.00M-39.8%2016$9.97M-29.4%2015$14.13M-0.8%2014$14.24M+3.8%2013$13.72M-38.1%2012$22.18M+172.6%2011$8.13M-70.8%2010$27.82M-36.0%2009$43.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share